- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-10-0002328

About Carus Laboratories Private Limited
Data last updated:
Carus Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 30 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2005PTC144250. Its GSTIN is 06AADCC4694A1ZX (Haryana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Jitender Pal Pilani and Krishna Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 164 Pocket 24 Sector 24 Rohini Delhi Rohini Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹128.85 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹20.05 Cr (net margin 15.6%) and EBITDA of ₹27.8 Cr (EBITDA margin 21.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 26% over five years.
The company has about 579 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Carus Laboratories. As per MCA filings, the company has satisfied charges of ₹30 Lakh on record. Court records list 19 cases involving the company, including 19 filed by the company; 7 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹19 Lakh; the latest was in November 2012. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 4 micro and small suppliers.
Carus Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0002328). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website caruslab.com.
Company details
Recognitions & Rankings of Carus Laboratories
Contact details
Carus Laboratories Private Limited's registered office is in Delhi, Delhi. Its website is caruslab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address164 Pocket 24 Sector 24 Rohini Delhi Rohini Delhi, Delhi, India
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Carus Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Carus Laboratories operates one associated brand: Carus Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive solutions for veterinary feed supplements. | caruslab.com |
Business activity
The main business activity of Carus Laboratories is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Carus Laboratories Private Limited, buy the company report.
Financials of Carus Laboratories Private Limited
FY 2024 filings availableCarus Laboratories Private Limited reported revenue of ₹128.85 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 24% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 15.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Carus Laboratories Private Limited, buy the company report.
Board of directors of Carus Laboratories Private Limited
Carus Laboratories has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitender Pal Pilani | Director | 30 Dec 2005 | 20 Years 9 Months | Current |
| Krishna Devi | Director | 30 Dec 2005 | 20 Years 9 Months | Current |
| Arun Pilani | Director | 05 Jul 2012 | 14 Years 3 Months | Current |
Auditor
Carus Laboratories Private Limited is audited by HARJINDER SINGH AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARJINDER SINGH AND CO. | FY 2023 | 014119N |
Shareholding
The shareholding of Carus Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Carus Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jun 2011 | 10372339 | Punjab National Bamk | ₹30 Lakh | Satisfied |
To see the full charge records of Carus Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Carus Laboratories Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹19 Lakh; the latest was in November 2012.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2012 | Funding round | ₹19 Lakh | Investors: 3 individuals |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Carus Laboratories Private Limited has 19 court cases on record: 19 filed by Carus Laboratories. 7 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 0 | 6 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Civil suit | Filed by the company against an individual | Pending |
| District court, Karnal, Haryana | Civil suit | Filed by the company against Bansal Agro Industry | Pending |
| District court, Karnal, Haryana | Civil suit | Filed by the company against Sahej Industries Near Telepone Exchange, Guruharsahai | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against Novelty Pharmaceuticals | Pending |
| High Court, HARYANA | Writ petition | Filed by the company against individuals | Pending |
To see the full case history of Carus Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Carus Laboratories Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Prabhat Agrochem Private Limited | |||
| Malhotra Bros & Co Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Carus Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Carus Laboratories Private Limited has a workforce of 579 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Carus Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCC4694A1ZX | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Carus Laboratories Private Limited, buy the company report.
Recent activity
Carus Laboratories Private Limited has 3 board changes on record since 2005: 3 appointments. The latest: Arun Pilani was appointed as Director on 05 Jul 2012.
Frequently asked questions
Carus Laboratories is an active private limited company based in Delhi, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 30 December 2005 (21+ years old) and is registered under CIN U24231DL2005PTC144250.
Carus Laboratories has 3 current directors:
- Jitender Pal Pilani - Director
- Krishna Devi - Director
- Arun Pilani - Director
The latest financial statements of Carus Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Carus Laboratories is 06AADCC4694A1ZX, registered in Haryana.
The CIN (Corporate Identification Number) of Carus Laboratories is U24231DL2005PTC144250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Carus Laboratories has 19 court cases on record: 19 filed by the company. 7 are pending. Most are in the district courts.
Carus Laboratories was incorporated on 30 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Carus Laboratories has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹19 Lakh; the latest was in November 2012.
Arun Pilani was appointed as Director on 05 Jul 2012. Jitender Pal Pilani was appointed as Director on 30 Dec 2005. Krishna Devi was appointed as Director on 30 Dec 2005.
Yes, Carus Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-10-0002328).
Carus Laboratories has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 4 micro and small suppliers. The latest return was filed on 17 May 2019.